160 related articles for article (PubMed ID: 1884892)
1. Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus.
Eriksson J; Saloranta C; Widén E; Ekstrand A; Franssila-Kallunki A; Schalin C; Groop L
Diabetologia; 1991 Mar; 34(3):192-7. PubMed ID: 1884892
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolism and insulin resistance in cirrhosis.
Kaye GL; Kruszynska YT; Harry DS; Heslop K; Johnston DG; McIntyre N
J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes.
Gelding SV; Coldham N; Niththyananthan R; Anyaoku V; Johnston DG
Diabet Med; 1995 Jan; 12(1):66-73. PubMed ID: 7712708
[TBL] [Abstract][Full Text] [Related]
4. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
Widén EI; Eriksson JG; Groop LC
Diabetes; 1992 Mar; 41(3):354-8. PubMed ID: 1551495
[TBL] [Abstract][Full Text] [Related]
5. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus.
Saloranta C; Franssila-Kallunki A; Ekstrand A; Taskinen MR; Groop L
Diabetologia; 1991 Jun; 34(6):409-15. PubMed ID: 1884899
[TBL] [Abstract][Full Text] [Related]
6. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
Osei K
Diabetes Res Clin Pract; 1992 Sep; 17(3):169-82. PubMed ID: 1425156
[TBL] [Abstract][Full Text] [Related]
7. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
[TBL] [Abstract][Full Text] [Related]
8. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
Eriksson JW; Smith U; Waagstein F; Wysocki M; Jansson PA
Diabetes; 1999 Aug; 48(8):1572-8. PubMed ID: 10426375
[TBL] [Abstract][Full Text] [Related]
9. Insulin sensitivity in non-diabetic relatives of patients with non-insulin-dependent diabetes from two ethnic groups.
Gelding SV; Niththyananthan R; Chan SP; Skinner E; Robinson S; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1994 Jan; 40(1):55-62. PubMed ID: 8306481
[TBL] [Abstract][Full Text] [Related]
10. Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes.
Tura A; Pacini G; Winhofer Y; Bozkurt L; Di Benedetto G; Morbiducci U; Roden M; Kautzky-Willer A
Diabet Med; 2012 Mar; 29(3):351-8. PubMed ID: 21988496
[TBL] [Abstract][Full Text] [Related]
11. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
[TBL] [Abstract][Full Text] [Related]
12. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty.
Arslanian SA; Kalhan SC
Diabetes; 1994 Jul; 43(7):908-14. PubMed ID: 8013756
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
14. Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patients.
Wang C; Tan H; Yu H; Zhang X; Suo L; Lu Z; Pu S; Yu Y
Diabetes Res Clin Pract; 2011 Jan; 91(1):67-71. PubMed ID: 21051097
[TBL] [Abstract][Full Text] [Related]
15. Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.
Golay A; DeFronzo RA; Ferrannini E; Simonson DC; Thorin D; Acheson K; Thiébaud D; Curchod B; Jéquier E; Felber JP
Diabetologia; 1988 Aug; 31(8):585-91. PubMed ID: 3065112
[TBL] [Abstract][Full Text] [Related]
16. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
[TBL] [Abstract][Full Text] [Related]
17. Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids.
Byrne CD; Wareham NJ; Brown DC; Clark PM; Cox LJ; Day NE; Palmer CR; Wang TW; Williams DR; Hales CN
Diabetologia; 1994 Sep; 37(9):889-96. PubMed ID: 7806018
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma non-esterified fatty acid levels and insulin secretion in non-diabetic relatives of type 2 diabetic patients.
Butler TJ; Barriocanal LA; Walker M
Clin Endocrinol (Oxf); 2001 Sep; 55(3):349-55. PubMed ID: 11589678
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
[TBL] [Abstract][Full Text] [Related]
20. Sustained endogenous glucose production, diminished lipolysis and non-esterified fatty acid appearance and oxidation in non-obese women at high risk of type 2 diabetes.
Forbes S; Robinson S; Dungu J; Anyaoku V; Bannister P; Forster D; Dissanayake S; McCarthy MI; MacDonald IA; Venkatesan S; Johnston DG
Eur J Endocrinol; 2006 Sep; 155(3):469-76. PubMed ID: 16914602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
